ATRA vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

ATRA

58.2
AI Score
VS
ATRA Wins

CLYM

48.2
AI Score

Investment Advisor Scores

ATRA

58score
Recommendation
HOLD

CLYM

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ATRA CLYM Winner
Net Income 32.69M -41.79M ATRA
Operating Income 35.86M -47.46M ATRA
ROE -84.9% -18.3% CLYM
ROA 161.5% -17.7% ATRA
Total Assets 20.23M 236.56M CLYM
Cash 8.48M 39.73M CLYM
Current Ratio 0.82 26.58 CLYM

Relative Price Performance (Last 90 Days)

ATRA 1M: -17.1% · 3M: -2.0% CLYM 1M: +5.6% · 3M: -33.4%

Current Technical Phase

ATRA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.3%), weak momentum, RSI 41

RSI (14): 41.1 · Price: $7.93

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.9 · Price: $10.87

Fundamentals Snapshot

Metric ATRA CLYM
Market Cap — —
Forward P/E 5.1 -10.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.6% 0.0%
Gross Margin -5.5% —
Operating Margin 0.0% 0.0%
EPS -1.12 -0.81
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ATRA is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.